Conference Proceedings

Lorlatinib in patients with ALK plus NSCLC treated beyond initial disease progression

SI Ou, B Solomon, A Shaw, SM Gadgeel, B Besse, RA Soo, A Abbattista, H Thurm, F Toffalorio, RJ Wiltshire, A Bearz

ANNALS OF ONCOLOGY | ELSEVIER | Published : 2020